203 related articles for article (PubMed ID: 7190870)
1. Lack of clinical therapeutic synergism between cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) in metastatic human colorectal carcinoma.
O'Connell MJ; Moertel CG; Rubin J; Schutt AJ; Creagan ET
Cancer Treat Rep; 1980; 64(2-3):311-3. PubMed ID: 7190870
[TBL] [Abstract][Full Text] [Related]
2. Adriamycin and cis-dichlorodiammineplatinum in nonresectable and metastatic carcinoma of the lung.
Morris RW; Brubaker LH; Kardinal CG; Carolla RL; Perry MC
Cancer Clin Trials; 1979; 2(1):37-41. PubMed ID: 229982
[TBL] [Abstract][Full Text] [Related]
3. cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lung.
Britell JC; Eagan RT; Ingle JN; Creagen ET; Rubin J; Frytak S
Cancer Treat Rep; 1978 Aug; 62(8):1207-10. PubMed ID: 688256
[TBL] [Abstract][Full Text] [Related]
4. Adriamycin-cyclophosphamide and adriamycin-cis-dichloro-diammineplatinum(II) combination chemotherapy in patients with advanced cancer.
Higby DJ; Wilbur D; Wallace HJ; Henderson ES; Weiss R
Cancer Treat Rep; 1977 Aug; 61(5):869-73. PubMed ID: 329980
[TBL] [Abstract][Full Text] [Related]
5. Adriamycin, mitomycin C, and 5-fluorouracil in combination for advanced colorectal adenocarcinoma previously treated with 5-fluorouracil.
Kessinger MA; Foley JF; Lemon HM
Cancer Clin Trials; 1979; 2(4):317-9. PubMed ID: 394867
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy for colorectal cancer with a combination of 5-fluorouracil, mitomycin C, adriamycin, and cytosine arabinoside: a pilot study.
Davis S; Park YK
Cancer Treat Rep; 1978 Oct; 62(10):1557-9. PubMed ID: 709556
[TBL] [Abstract][Full Text] [Related]
7. A role of cis-dichlorodiammineplatinum(II) in squamous cell lung cancer.
Eagan RT; Fleming TR; Frytak S; Creagan ET; Ingle JN; Kvols LK
Cancer Treat Rep; 1980 Jan; 64(1):87-91. PubMed ID: 6991107
[TBL] [Abstract][Full Text] [Related]
8. Phase II evaluation of 4'-epi-doxorubicin in patients with advanced colorectal carcinoma.
Michaelson R; Kemeny N; Young C
Cancer Treat Rep; 1982 Sep; 66(9):1757-8. PubMed ID: 6956441
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy for ovarian carcinoma with cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) after failure of initial chemotherapy.
Bruckner HW; Ratner LH; Cohen CJ; Wallach R; Kabakow B; Greenspan EM; Holland JF
Cancer Treat Rep; 1978 Jul; 62(7):1021-3. PubMed ID: 688244
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer.
Haller DG; Woolley PV; Macdonald JS; Smith LF; Schein PS
Cancer Treat Rep; 1978 Apr; 62(4):563-5. PubMed ID: 350394
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum (II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung.
Eagan RT; Frytak S; Creagan ET; Ingle JN; Kvols LK; Coles DT
Cancer Treat Rep; 1979; 63(9-10):1589-91. PubMed ID: 227597
[No Abstract] [Full Text] [Related]
12. [Cis-dichlorodiammineplatinum, adriamycin and cyclophosphamide versus cis-dichlorodiammineplatinum, adriamycin, cyclophosphamide and CCNU in non-small cell carcinoma of the lung].
Sanz Ortiz J; Saiz García F
Med Clin (Barc); 1982 Nov 16-30; 79(9):403-6. PubMed ID: 6296560
[No Abstract] [Full Text] [Related]
13. Phase II trial cisplatin, doxorubicin, and cyclophosphamide (CAP) in the treatment of urothelial transitional cell carcinoma.
Campbell M; Baker LH; Opipari M; Al-Sarraf M
Cancer Treat Rep; 1981; 65(9-10):897-9. PubMed ID: 7196800
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy for stage III-IV epithelial ovarian cancer with cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide: a preliminary report.
Ehrlich CE; Einhorn L; Williams SD; Morgan J
Cancer Treat Rep; 1979 Feb; 63(2):281-8. PubMed ID: 376134
[No Abstract] [Full Text] [Related]
15. cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice.
Schabel FM; Trader MW; Laster WR; Corbett TH; Griswold DP
Cancer Treat Rep; 1979; 63(9-10):1459-73. PubMed ID: 291480
[TBL] [Abstract][Full Text] [Related]
16. Phase II study in advanced sarcoma: randomized trial of pyrazofurin versus combination cyclophosphamide, doxorubicin, and cis-dichlorodiammineplatinum(II) (CAP).
Cormier WJ; Hahn RG; Edmonson JH; Eagan RT
Cancer Treat Rep; 1980; 64(4-5):655-8. PubMed ID: 7191779
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of cyclophosphamide and cytarabine in the treatment of metastatic adenocarcinoma of the colon and rectum.
Denefrio JM; Kaplan RS; Eisenberger MA; Lessner HE
Cancer Treat Rep; 1981; 65(1-2):163-4. PubMed ID: 7226166
[No Abstract] [Full Text] [Related]
18. Cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin (CHAD) as second-line chemotherapy for ovarian adenocarcinoma.
Piver MS; Lele S; Barlow JJ
Cancer Treat Rep; 1981; 65(1-2):149-51. PubMed ID: 6784921
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy for advanced gynecological carcinoma with cis-dichlorodiammineplatinum (II), adriamycin and/or cyclophosphamide after failure of initial treatment (author's transl)].
Takizawa K; Matsuzawa M; Takahashi M; So E; Hasumi K; Sampi K
Nihon Gan Chiryo Gakkai Shi; 1981 Oct; 16(6):1292-1302. PubMed ID: 7199554
[No Abstract] [Full Text] [Related]
20. Combination chemotherapy for advanced carcinoma of the fallopian tube.
Deppe G; Bruckner HW; Cohen CJ
Obstet Gynecol; 1980 Oct; 56(4):530-2. PubMed ID: 7191548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
